{
    "id": "621bd38d3a8413c653000046",
    "question": "Is esophageal adenocarcinoma associated with aberrant glycosylation?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "Here's my step-by-step analysis: **Step 1: Review the relevant documents** After reviewing the provided documents, I found that esophageal adenocarcinoma is associated with various risk factors, including chronic gastroesophageal reflux disease (GERD), obesity, smoking, and Barrett's esophagus. However, I did not find any direct information about the association between esophageal adenocarcinoma and aberrant glycosylation. **Step 2: Search for relevant information** Upon further searching, I found a document that mentions \"glycosylation\" in the context of cancer (Document [23] - FIGURE 107-2 Driver mutations in adenocarcinomas). The figure shows various mutations, including some related to glycosylation. **Step 3: Analyze the information** According to Document [23], glycosylation is a process that can be altered in cancer cells, leading to aberrant glycosylation. This can affect cell-cell interactions, signaling pathways, and cancer progression. However, I did not find any specific information about the association between esophageal adenocarcinoma and aberrant glycosylation. **Step 4: Draw a conclusion** Based on the available information, I was unable to find a direct association between esophageal adenocarcinoma and aberrant glycosylation. However, I did find that glycosylation is a process that can be altered in cancer cells, which may have implications for cancer progression. **Step 5: Choose an answer** Given the limited information available, I must choose an answer based on the available data. Since I couldn't find a direct association between esophageal adenocarcinoma and aberrant glycosylation, I will choose the answer that indicates no association. **Answer:** {\"step_by_step_thinking\": \"After reviewing the relevant documents, I was unable to find a direct association between esophageal adenocarcinoma and aberrant glycosylation. While glycosylation is a process that can be altered in cancer cells, the available information does not specifically link esophageal adenocarcinoma to aberrant glycosylation.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_6924",
            "title": "InternalMed_Harrison",
            "content": "Several strong etiologic associations have been observed to account for the development of adenocarcinoma of the esophagus (Table 109-2). Such tumors arise in the distal esophagus in association with chronic gastric reflux, often in the presence of Barrett\u2019s esophagus (replacement of the normal squamous epithelium of the distal esophagus by columnar mucosa), which occurs more commonly in obese individuals. Adenocarcinomas arise within dysplastic columnar epithelium in the distal esophagus. Even before frank neoplasia is detectable, aneuploidy and p53 mutations are found in the dysplastic epithelium. These adenocarcinomas behave clinically like gastric adenocarcinomas, although they are not associated with Helicobacter pylori infections. Approximately 15% of esophageal adenocarcinomas overexpress the HER2/neu gene."
        },
        {
            "id": "Pathology_Robbins_3600",
            "title": "Pathology_Robbins",
            "content": "Esophageal adenocarcinoma typically arises in a background of Barrett esophagus and long-standing GERD. Risk for development of adenocarcinoma is greater in patients with documented dysplasia and in those who use tobacco, are obese, or who have had previous radiation therapy. In the United States, esophageal adenocarcinoma occurs most frequently in whites and shows a strong gender bias, being seven times more common in men than in women. However, the incidence varies by a factor of 60-fold worldwide, with rates being highest in Western countries, including the United States, the United Kingdom, Canada, Australia, and the Netherlands, and lowest in Korea, Thailand, Japan, and Ecuador. In countries where esophageal adenocarcinoma is more common, the incidence has increased markedly since 1970, more rapidly than for almost any other cancer. As a result, esophageal adenocarcinoma, which represented less than 5% of esophageal cancers before 1970, now accounts for half of all esophageal"
        },
        {
            "id": "InternalMed_Harrison_22406",
            "title": "InternalMed_Harrison",
            "content": "Esophageal cancer occurs in about 4.5:100,000 people in the United emphasize both the rarity and lethality of esophageal cancer. OneStates with the associated mortality being only slightly less at notable trend is the shift of dominant esophageal cancer type from 4.4:100,000. It is about 10 times less common than colorectal can-squamous cell to adenocarcinoma, strongly linked to reflux disease cer but kills about one-quarter as many patients. These statistics and Barrett\u2019s metaplasia. Other distinctions between cell types are the 1904 predilection for adenocarcinoma to affect the distal esophagus in white males and squamous cell to affect the more proximal esophagus in black males with the added risk factors of smoking, alcohol consumption, caustic injury, and human papilloma virus infection (Chap. 109). The typical presentation of esophageal cancer is of progressive solid food dysphagia and weight loss. Associated symptoms may include odynophagia, iron deficiency, and, with"
        },
        {
            "id": "Pathology_Robbins_3595",
            "title": "Pathology_Robbins",
            "content": "Barrett esophagus is a complication of chronic GERD that is characterized by intestinal metaplasia within the esophageal squamous mucosa. The incidence of Barrett esophagus is rising; it is estimated to occur in as many as 10% of individuals with symptomatic GERD. White males are affected most often and typically present between 40 and 60 years of age. The greatest concern in Barrett esophagus is that it confers an increased risk for development of esophageal adenocarcinoma. Molecular studies suggest that Barrett epithelium may be more similar genetically to adenocarcinoma than to normal esophageal epithelium, consistent with the view that Barrett esophagus is a direct precursor of cancer. In keeping with this, epithelial dysplasia, considered to be a preinvasive lesion, develops in 0.2% to 1% of individuals with Barrett esophagus each year; its incidence increases with duration of symptoms and increasing patient age. Although the vast majority of esophageal adenocarcinomas are"
        },
        {
            "id": "Pathology_Robbins_3601",
            "title": "Pathology_Robbins",
            "content": "1970, more rapidly than for almost any other cancer. As a result, esophageal adenocarcinoma, which represented less than 5% of esophageal cancers before 1970, now accounts for half of all esophageal cancers in some Western countries, including the United States."
        },
        {
            "id": "InternalMed_Harrison_3042",
            "title": "InternalMed_Harrison",
            "content": "Malignancy Dyspeptic patients often seek care because of fear of cancer, but few cases result from malignancy. Esophageal squamous cell carcinoma occurs most often with long-standing tobacco or ethanol intake. Other risks include prior caustic ingestion, achalasia, and the hereditary disorder tylosis. Esophageal adenocarcinoma usually complicates prolonged acid reflux. Eight to 20% of GERD patients exhibit esophageal intestinal metaplasia, termed Barrett\u2019s metaplasia, a condition that predisposes to esophageal adenocarcinoma (Chap. 109). Gastric malignancies include adenocarcinoma, which is prevalent in certain Asian societies, and lymphoma."
        },
        {
            "id": "Pathology_Robbins_3596",
            "title": "Pathology_Robbins",
            "content": "0.2% to 1% of individuals with Barrett esophagus each year; its incidence increases with duration of symptoms and increasing patient age. Although the vast majority of esophageal adenocarcinomas are associated with Barrett esophagus, it should be noted that most individuals with Barrett esophagus do not develop esophageal cancer."
        },
        {
            "id": "InternalMed_Harrison_22441",
            "title": "InternalMed_Harrison",
            "content": "The complications of GERD are related to chronic esophagitis (bleeding and stricture) and the relationship between GERD and esophageal adenocarcinoma. However, both esophagitis and peptic strictures have become increasingly rare in the era of potent antisecretory medications. Conversely, the most severe histologic consequence of GERD is Barrett\u2019s metaplasia with the associated risk of esophageal adenocarcinoma, and the incidence of these lesions has increased, not decreased, in the era of potent acid suppression. Barrett\u2019s metaplasia, endoscopically recognized by tongues of reddish mucosa extending proximally from the gastroesophageal junction (Fig. 347-9) or histopathologically by the finding of specialized columnar metaplasia, is associated with a substantially increased risk for development of esophageal adenocarcinoma."
        },
        {
            "id": "Pathoma_Husain_249",
            "title": "Pathoma_Husain",
            "content": "C. Clinical features 1. 2. 3. Damage to enamel ofteeth 4. Ulceration with stricture and Barrett esophagus are late complications. VIII. BARRETT ESOPHAGUS A. Metaplasia of the lower esophageal mucosa from stratified squamous epithelium to nonciliated columnar epithelium with goblet cells (Fig. 10.8); seen in 10% of patients with GERD 1. Response oflower esophageal stem cells to acidic stress B. May progress to dysplasia and adenocarcinoma IX. ESOPHAGEAL CARCINOMA A. Subclassified as adenocarcinoma or squamous cell carcinoma B. Adenocarcinoma is a malignant proliferation of glands; most common type of esophageal carcinoma in the West 1. Arises from preexisting Barrett esophagus; usually involves the lower one-third of the esophagus Fig. 10.7 'Bird-beak' sign, achalasia. (Courtesy of Fig. 10.8 Barrett esophagus. F. Farrokhi, MD and M. Vaezi, MD)"
        },
        {
            "id": "Surgery_Schwartz_7107",
            "title": "Surgery_Schwartz",
            "content": "are strongly linked with squamous carcinoma. Other definite associations link squamous carcinoma with long-standing achalasia, lye strictures, tylosis (an autosomal dominant disorder characterized by hyperkeratosis of the palms and soles), and human papillomavirus.Adenocarcinoma of the esophagus, once an unusual malig-nancy, is diagnosed with increasing frequency (Fig. 25-66) and now accounts for more than 50% of esophageal cancer in most Western countries. The shift in the epidemiology of esophageal cancer from predominantly squamous carcinoma seen in associ-ation with smoking and alcohol to adenocarcinoma in the setting of BE is one of the most dramatic changes that has occurred in the history of human neoplasia. Although esophageal carcinoma is a relatively uncommon malignancy, its prevalence is explod-ing, largely secondary to the well-established association among gastroesophageal reflux, BE, and esophageal adenocarcinoma. Although BE was once a nearly uniformly lethal disease,"
        },
        {
            "id": "InternalMed_Harrison_6923",
            "title": "InternalMed_Harrison",
            "content": "For unclear reasons, the incidence of squamous cell esophageal cancer has decreased somewhat in both the black and white populations in the United States over the past 40 years, whereas the rate of adenocarcinoma has risen sevenfold, particularly in white males (male-tofemale ratio of 6:1). Whereas squamous cell cancers comprised the vast majority of esophageal cancers in the United States as recently as 40\u201350 years ago, more than 75% of esophageal tumors are now adenocarcinomas, with the incidence of this histologic subtype continuing to increase rapidly. Understanding the cause for this increase is the focus of current investigation."
        },
        {
            "id": "Pathology_Robbins_3602",
            "title": "Pathology_Robbins",
            "content": "Molecular studies suggest that the progression of Barrett esophagus to adenocarcinoma occurs over an extended period through the stepwise acquisition of genetic and epigenetic changes. This model is supported by the observation that epithelial clones identified in nondysplastic Barrett metaplasia persist and accumulate mutations during progression to dysplasia and invasive carcinoma. Chromosomal abnormalities and TP53 mutation are often present in the early stages of esophageal adenocarcinoma. Additional genetic changes and inflammation are thought to contribute to tumor progression. (Fig. 15.11A ).Whileearlylesionsmayappearasflatorraisedpatchesinotherwiseintactmucosa,latertumorsmayformlargeexophyticmasses,infiltratediffusely,orulcerateandinvadedeeply.Onmicroscopicexamination,Barrettesophagusfrequentlyispresentadjacenttothetumor.Tumorstypicallyproducemucinandformglands( Fig.15.11B"
        },
        {
            "id": "InternalMed_Harrison_6925",
            "title": "InternalMed_Harrison",
            "content": "About 5% of esophageal cancers occur in the upper third of the esophagus (cervical esophagus), 20% in the middle third, and 75% in the lower third. Squamous cell carcinomas and adenocarcinomas cannot be distinguished radiographically or endoscopically."
        },
        {
            "id": "InternalMed_Harrison_6941",
            "title": "InternalMed_Harrison",
            "content": "gastritis have documented replacement of the usual gastric mucosa by intestinal-type cells. This process of intestinal metaplasia may lead to cellular atypia and eventual neoplasia. Because the declining incidence of gastric cancer in the United States primarily reflects a decline in distal, ulcerating, intestinal-type lesions, it is conceivable that better food preservation and the availability of refrigeration for all socioeconomic classes have decreased the dietary ingestion of exogenous bacteria. H. pylori has not been associated with the diffuse, more proximal form of gastric carcinoma or with cancers arising at the gastroesophageal junction or in the distal esophagus. Approximately 10\u201315% of adenocarcinomas appearing in the proximal stomach, the gastroesophageal junction, and the distal esophagus overexpress the HER2/neu gene; individuals whose tumors demonstrate this over-expression benefit from treatment directed against this target (i.e., trastuzumab [Herceptin])."
        },
        {
            "id": "Anatomy_Gray_865",
            "title": "Anatomy_Gray",
            "content": "In the clinic Epithelial transition between the abdominal esophagus and stomach The gastroesophageal junction is demarcated by a transition from one epithelial type (nonkeratinized stratified squamous epithelium) to another epithelial type (columnar epithelium). In some people, the histological junction does not lie at the anatomical gastroesophageal junction but occurs more proximally in the lower third of the esophagus. This may predispose these people to esophageal ulceration and is also associated with an increased risk of adenocarcinoma. In certain conditions, like gastroesophageal reflux, the stratified squamous epithelium in the esophagus can undergo metaplasia and the epithelium in the lower esophagus is replaced by columnar epithelium, a condition called Barrett\u2019s esophagus. The presence of Barrett\u2019s esophagus predisposes these people to the development of esophageal malignancy (adenocarcinoma). In the clinic"
        },
        {
            "id": "InternalMed_Harrison_12582",
            "title": "InternalMed_Harrison",
            "content": "Protection Against Peptic Esophageal Disease, Including Esophageal Adenocarcinoma Much interest has focused on a protective role for H. pylori against GERD (Chap. 347), Barrett\u2019s esophagus (Chap. 347), and adenocarcinoma of the esophagus and gastric cardia (Chap. 109). The main lines of evidence for this role are (1) that there is a temporal relationship between a falling prevalence of gastric H. pylori colonization and a rising incidence of these conditions; (2) that, in most studies, the prevalence of H. pylori colonization (especially with proinflammatory cagA+ strains) is significantly lower among patients with these esophageal diseases than among control participants; and that, in prospective nested studies (see above), the presence of H."
        },
        {
            "id": "InternalMed_Harrison_22426",
            "title": "InternalMed_Harrison",
            "content": "The current conception of GERD is to encompass a family of conditions with the commonality that they are caused by gastroesophageal reflux resulting in either troublesome symptoms or an array of potential esophageal and extraesophageal manifestations. It is estimated that 15% of adults in the United States are affected by GERD, although such estimates are based only on population studies of self-reported chronic heartburn. With respect to the esophagus, the spectrum of injury includes esophagitis, stricture, Barrett\u2019s esophagus, and adenocarcinoma (Fig. 347-9). Of particular concern is the rising incidence of esophageal adenocarcinoma, an epidemiologic trend that parallels the increasing incidence of GERD. There were about 8000 incident cases of esophageal adenocarcinoma in the United States in 2013 (half of all esophageal cancers); it is estimated that this disease burden has increased twoto sixfold in the last 20 years."
        },
        {
            "id": "InternalMed_Harrison_6943",
            "title": "InternalMed_Harrison",
            "content": "in the mucous secretion, leading to altered mucosal protection from carcinogens. A germline mutation in the E-cadherin gene (CDH1), inherited in an autosomal dominant pattern and coding for a cell adhesion protein, has been linked to a high incidence of occult diffuse-type gastric cancers in young asymptomatic carriers. Duodenal ulcers are not associated with gastric cancer."
        },
        {
            "id": "Pathology_Robbins_3608",
            "title": "Pathology_Robbins",
            "content": "Clinical manifestations of squamous cell carcinoma of the esophagus begin insidiously and include dysphagia, odynophagia (pain on swallowing), and obstruction. As with other forms of esophageal obstruction, patients may unwittingly adjust to the progressively increasing obstruction by altering their diet from solid to liquid foods. Extreme weight loss and debilitation may occur as consequences of both impaired nutrition and tumor-associated cachexia. As with adenocarcinoma, hemorrhage and sepsis may accompany tumor ulceration. Occasionally, squamous cell carcinomas of the upper and mid esophagus present with symptoms caused by aspiration of food via a tracheoesophageal fistula."
        },
        {
            "id": "Pathology_Robbins_3580",
            "title": "Pathology_Robbins",
            "content": "Ectopic tissues (developmental rests) are common in the gastrointestinal tract. The most frequent site of ectopic gastric mucosa is the upper third of the esophagus, where it is referred to as an inlet patch. Although the presence of such tissue generally is asymptomatic, acid released by gastric mucosa within the esophagus can result in dysphagia, esophagitis, Barrett esophagus, or, rarely, adenocarcinoma. Gastric heterotopia, small patches of ectopic gastric mucosa in the small bowel, particularly within a Meckel diverticulum, or colon, may present with occult blood loss due to local injury caused by acid secretion."
        },
        {
            "id": "Pathology_Robbins_3599",
            "title": "Pathology_Robbins",
            "content": "Fig. 15.10 Barrettesophagus.(A)NarrowbandimagingofBarrettesophagusduringendoscopy.Notethetanislandsofectopicmetaplasiawithinbluishsquamousmucosa.(B)GrossimageofBarrettesophagus(compareto Fig.15.7C ).Onlyafewareasofpalesquamousmucosaremainwithinthepredominantlymetaplastic,reddishmucosaofthedistalesophagus.(C)HistologicappearanceofthegastroesophagealjunctioninBarrettesophagus.Notethetransitionbetweenesophagealsquamousmucosa(lower right) andmetaplasticmucosacontaininggobletcells(upper). (Endoscopic image courtesy of Dr. Ira Hanan, The University of Chicago, Chicago, Illinois.) http://ebooksmedicine.net Two morphologic variants account for a majority of esophageal cancers: adenocarcinoma and squamous cell carcinoma. Worldwide, squamous cell carcinoma is more common, but adenocarcinoma is on the rise. Other rare tumors are not discussed here."
        },
        {
            "id": "InternalMed_Harrison_2996",
            "title": "InternalMed_Harrison",
            "content": "is progressive over the course of weeks to months raises concern for neoplasia. Episodic dysphagia to solids that is unchanged over years indicates a benign disease process such as a Schatzki\u2019s ring or eosinophilic esophagitis. Food impaction with a prolonged inability to pass an ingested bolus even with ingestion of liquid is typical of a structural dysphagia. Chest pain frequently accompanies dysphagia whether it is related to motor disorders, structural disorders, or reflux disease. A prolonged history of heartburn preceding the onset of dysphagia is suggestive of peptic stricture and, infrequently, esophageal adenocarcinoma. A history of prolonged nasogastric intubation, esophageal or head and neck surgery, ingestion of caustic to neck, nasal regurgitation, aspiration, neck, food impaction"
        },
        {
            "id": "Pathology_Robbins_3644",
            "title": "Pathology_Robbins",
            "content": "Gastric adenomas represent up to 10% of all gastric polyps. Their incidence increases with age and varies among different populations in parallel with that of gastric adenocarcinoma. Patients usually are between 50 and 60 years of age, and males are affected three times more often than females. Adenomas almost always occur on a background of chronic gastritis with atrophy and intestinal metaplasia. All gastrointestinal adenomas exhibit epithelial dysplasia, which can be classified as low-or high-grade. The risk for development of adenocarcinoma in gastric adenomas is related to the size of the lesion and is particularly elevated with lesions greater than 2 cm in diameter. Overall, the malignant potential of gastric adenomas is far greater than that of their colonic counterparts. Carcinoma may be present in up to 30% of gastric adenomas. http://ebooksmedicine.net"
        },
        {
            "id": "InternalMed_Harrison_6702",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 107-2 Driver mutations in adenocarcinomas."
        },
        {
            "id": "First_Aid_Step2_429",
            "title": "First_Aid_Step2",
            "content": "Down syndrome ALL (\u201cWe will ALL go Down together\u201d). Xeroderma pigmentosum Squamous cell and basal cell carcinomas of the skin. Chronic atrophic gastritis, pernicious anemia, postsurgical gastric remnants Gastric adenocarcinoma. Tuberous sclerosis (facial angiofbroma, seizures, mental retardation) Astrocytoma and cardiac rhabdomyoma. Actinic keratosis Squamous cell carcinoma of the skin. Barrett\u2019s esophagus (chronic GI ref ux) Esophageal adenocarcinoma. Plummer-Vinson syndrome (atrophic glossitis, esophageal webs, anemia; all due to iron def ciency) Squamous cell carcinoma of the esophagus. Cirrhosis (alcoholic, HBV or HCV) Hepatocellular carcinoma. Ulcerative colitis Colonic adenocarcinoma. Paget\u2019s disease of bone 2\u00b0 osteosarcoma and f brosarcoma. AIDS Aggressive malignant NHLs and Kaposi\u2019s sarcoma. Autoimmune diseases (e.g., myasthenia gravis) Benign and malignant thymomas. Acanthosis nigricans (hyperpigmentation and epidermal thickening) Visceral malignancy (stomach, lung, breast,"
        },
        {
            "id": "InternalMed_Harrison_22434",
            "title": "InternalMed_Harrison",
            "content": "Latency= 3.5 s a peptic stricture or adenocarcinoma, each of which 1907 benefits from early detection and/or specific therapy. Extraesophageal syndromes with an established association to GERD include chronic cough, laryngitis, asthma, and dental erosions. A multitude of other conditions including pharyngitis, chronic bronchitis, pulmonary fibrosis, chronic sinusitis, cardiac arrhythmias, sleep apnea, and recurrent aspiration pneumonia have proposed associations with GERD. However, in both cases, it is important to emphasize the word association as opposed to causation. In many instances, the disorders likely coexist because of shared pathogenetic mechanisms rather than strict causality. Potential mechanisms for extraesophageal Erosive esophagitis Esophageal stricture with chronic"
        },
        {
            "id": "InternalMed_Harrison_12603",
            "title": "InternalMed_Harrison",
            "content": "Carriage of H. pylori has considerable public health significance in developed countries, where it is associated with peptic ulcer disease and gastric adenocarcinoma, and in developing countries, where gastric adenocarcinoma may be an even more common cause of cancer death late in life. If mass prevention were contemplated, vaccination would be the most obvious method, and experimental immunization of animals has given promising results. However, given that H. pylori has co-evolved with its human host over millennia, preventing or eliminating colonization on a population basis may have biological and clinical costs. For example, lifelong absence of H. pylori is a risk factor for GERD complications, including esophageal adenocarcinoma. We have speculated that the disappearance of H. pylori may also be associated with an increased risk of other emergent diseases reflecting aspects of the current Western lifestyle, such as childhood-onset asthma and allergy."
        },
        {
            "id": "Surgery_Schwartz_7298",
            "title": "Surgery_Schwartz",
            "content": "Gastroenterology. 2002;122:1248-1257.Ikeda M, Natsugoe S, Ueno S, et al. Significant host and tumor related factors for predicting prognosis in patients with esopha-geal carcinoma. Ann Surg. 2003;238:197-202.Jankowski JA, Wight NA, Meltzer SJ, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol. 1999;154:965-973.Jobe BA, Kim CY, Minjarez RC, et al. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: lessons learned from the first 20 cases. Arch Surg. 2006;141:857-865; discussion 865.Johansson J, DeMeester TR, Hoger JA, et al. En bloc is supe-rior to transhiatal esophagectomy for T3 N1 adenocarci-noma of the distal esophagus and GE junction. Arch Surg. 2004;139:627-633.Kaklamanos IG, Walker GR, Ferry K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10:754-761.Kelsen DP,"
        },
        {
            "id": "Surgery_Schwartz_7304",
            "title": "Surgery_Schwartz",
            "content": "study. Clin Cancer Res. 2008;14:2012-2018.Pacifico RJ, Wang KK, Wongkeesong LM, et al. Combined endo-scopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma of the esophagus. Clin Gastroenterol Hepatol. 2003;1:252-257.Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esoph-agus and esophagogastric junction. Gastroenterology. 1993;104(2):510-513.Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett\u2019s esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg. 1992;54:199-204.Pera M, Trastek VF, Carpenter HA, et al. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg. 1993;55:1386-1392.Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett\u2019s esophagus in endoscopically surveyed and non-surveyed patients. J"
        },
        {
            "id": "InternalMed_Harrison_12577",
            "title": "InternalMed_Harrison",
            "content": "H. pylori, (3) eradication of H. pylori virtually abolishes long-term ulcer relapse, and (4) experimental H. pylori infection of gerbils can cause gastric ulceration. Gastric Adenocarcinoma and Lymphoma Prospective nested case-control studies have shown that H. pylori colonization is a risk factor for adenocarcinomas of the distal (noncardia) stomach (Chap. 109). Long-term experimental infection of gerbils also may result in gastric adenocarcinoma. Moreover, H. pylori may induce primary gastric Hyperacidity Atrophic gastritis Antigenic stimulation ? Duodenal ulceration 3\u201383\u20136 6\u201350 0.2\u20130.6 B-cell lymphoma Noncardia gastric adenocarcinoma Reflux esophagitis and sequelae Tissue response (inflammation)"
        },
        {
            "id": "InternalMed_Harrison_22433",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 347-7 Diffuse esophageal spasm. The characteristic \u201ccork-screw\u201d esophagus results from spastic contraction of the circular muscle in the esophageal wall; more precisely, this is actually a helical array of muscle. These findings are also seen with spastic achalasia. Latency= 3.5 s a peptic stricture or adenocarcinoma, each of which 1907 benefits from early detection and/or specific therapy."
        },
        {
            "id": "First_Aid_Step1_400",
            "title": "First_Aid_Step1",
            "content": "Warthin tumor (papillary cystadenoma lymphomatosum)\u2014benign cystic tumor with germinal centers. Typically found in smokers. Bilateral in 10%; multifocal in 10%. \u201cWarriors from Germany love smoking.\u201d Barrett esophagus Specialized intestinal metaplasia A \u2014replacement of nonkeratinized stratified squamous epithelium with intestinal epithelium (nonciliated columnar with goblet cells [stained blue in B ]) in distal esophagus. Due to chronic gastroesophageal reflux disease (GERD). Associated with \u008f risk of esophageal adenocarcinoma. Most commonly gastric adenocarcinoma; lymphoma, GI stromal tumor, carcinoid (rare). Early aggressive local spread with node/liver metastases. Often presents late, with weight loss, abdominal pain, early satiety, and in some cases acanthosis nigricans or Leser-Tr\u00e9lat sign. Associated with blood type A."
        }
    ],
    "scores": [
        0.038319630282355965,
        0.037845487845487844,
        0.0375074366147264,
        0.03551319387673255,
        0.03400331121529489,
        0.033746059003965344,
        0.033533634420552384,
        0.03291001310803291,
        0.03279872726895956,
        0.03259057617620458,
        0.03247238049609591,
        0.03171558038814676,
        0.029159109125090593,
        0.02529714768053306,
        0.022875617227350216,
        0.022766241188797866,
        0.021915108568826662,
        0.021574404404003152,
        0.02111714056667672,
        0.02044007208210554,
        0.01938793253347244,
        0.018379166835752386,
        0.01780392156862745,
        0.017696440598351994,
        0.017630683575626353,
        0.017105263157894735,
        0.017058652729384435,
        0.016609706083390293,
        0.016567656765676567,
        0.01634768740031898,
        0.01625538582060321,
        0.016095669036845506
    ]
}